Effect of an LXR agonist on the growth of MMTV-PyMT mammary tumors
Our findings indicate that LXR activation reduces tumor development and increases survival Overall design: MMTV-PyMT mice were adminstered an LXR agonist by the oral route continuously beginning at 6 wk of age to measure the effect of LXR activation on tumor progression.